Saturation phase [Design Issues]
Dear Dixit!
Aka “saturation phase” (see this slide). The red line are concentrations after doses in the first period (“building up” steady state). The first profile is measured on day 5 (the fist yellow line). At the end of day 5 (120 hours) we switch directly to the other formulation (therefore, this is also called a “switch-over design”). During days 5–9 (the first green line) steady state of the second formulation is build up, whilst the first formulation is simultaneously eliminated (“washed out”). On day 10 we measure the second profile (the second yellow line). Such a design is preferable over a design with a treatment-free washout (days 6–9), where we would dose on days 10–14 (represented by the second green line) and measure the second profile on day 14 (the third yellow line). The duration of the study is shorter and chances of drop-outs lower.
Rationale: According to the superposition principle of pharmacokinetics steady state is independent from previous concentrations. In other words in steady state you see the same concentrations irrespective whether you start from zero or any other concentration level. You can see this in the plot, where the thin green lines are parallel, i.e., the steady state profile in a switch-over design is identical to the one obtained in a design with a wash-out.
❝ […] what does the word build up exactly mean
Aka “saturation phase” (see this slide). The red line are concentrations after doses in the first period (“building up” steady state). The first profile is measured on day 5 (the fist yellow line). At the end of day 5 (120 hours) we switch directly to the other formulation (therefore, this is also called a “switch-over design”). During days 5–9 (the first green line) steady state of the second formulation is build up, whilst the first formulation is simultaneously eliminated (“washed out”). On day 10 we measure the second profile (the second yellow line). Such a design is preferable over a design with a treatment-free washout (days 6–9), where we would dose on days 10–14 (represented by the second green line) and measure the second profile on day 14 (the third yellow line). The duration of the study is shorter and chances of drop-outs lower.
Rationale: According to the superposition principle of pharmacokinetics steady state is independent from previous concentrations. In other words in steady state you see the same concentrations irrespective whether you start from zero or any other concentration level. You can see this in the plot, where the thin green lines are parallel, i.e., the steady state profile in a switch-over design is identical to the one obtained in a design with a wash-out.
—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- build-up dixit 2012-08-28 11:33
- Saturation phaseHelmut 2012-08-28 14:26
- Saturation phase The Outlaw Torn 2013-06-21 13:48
- Switch-over (+example) Helmut 2013-06-21 15:03
- Switch-over The Outlaw Torn 2013-06-21 15:56
- Switch-over Helmut 2013-06-21 17:53
- Switch-over The Outlaw Torn 2013-06-21 15:56
- Switch-over (+example) Helmut 2013-06-21 15:03
- Saturation phase The Outlaw Torn 2013-06-21 13:48
- Saturation phaseHelmut 2012-08-28 14:26
